Airway Epithelial Nucleotide Release Contributes to Mucociliary Clearance.

ATP release airway epithelia mucociliary clearance pannexin 1 vesicular nucleotide transporter

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
11 May 2021
Historique:
received: 20 04 2021
accepted: 28 04 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Mucociliary clearance (MCC) is a dominant component of pulmonary host defense. In health, the periciliary layer (PCL) is optimally hydrated, thus acting as an efficient lubricant layer over which the mucus layer moves by ciliary force. Airway surface dehydration and production of hyperconcentrated mucus is a common feature of chronic obstructive lung diseases such as cystic fibrosis (CF) and chronic bronchitis (CB). Mucus hydration is driven by electrolyte transport activities, which in turn are regulated by airway epithelial purinergic receptors. The activity of these receptors is controlled by the extracellular concentrations of ATP and its metabolite adenosine. Vesicular and conducted pathways contribute to ATP release from airway epithelial cells. In this study, we review the evidence leading to the identification of major components of these pathways: (a) the vesicular nucleotide transporter VNUT (the product of the SLC17A9 gene), the ATP transporter mediating ATP storage in (and release from) mucin granules and secretory vesicles; and (b) the ATP conduit pannexin 1 expressed in non-mucous airway epithelial cells. We further illustrate that ablation of pannexin 1 reduces, at least in part, airway surface liquid (ASL) volume production, ciliary beating, and MCC rates.

Identifiants

pubmed: 34064654
pii: life11050430
doi: 10.3390/life11050430
pmc: PMC8151306
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Cystic Fibrosis Foundation
ID : BUTTON19GO
Organisme : NIH HHS
ID : R01 HL125280
Pays : United States
Organisme : NIH HHS
ID : R56 HL136909
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL125280
Pays : United States
Organisme : Cystic Fibrosis Foundation
ID : LAZARO19GO
Organisme : NIDDK NIH HHS
ID : P30 DK065988
Pays : United States

Références

Ann Am Thorac Soc. 2016 Apr;13 Suppl 2:S150-5
pubmed: 27115950
Purinergic Signal. 2012 Mar;8(1):59-70
pubmed: 21881960
FASEB J. 2012 Feb;26(2):533-45
pubmed: 21990373
FEBS Lett. 2004 Aug 13;572(1-3):65-8
pubmed: 15304325
Am J Physiol Lung Cell Mol Physiol. 2015 May 15;308(10):L1068-77
pubmed: 25795727
Science. 2008 Oct 24;322(5901):590-4
pubmed: 18772398
Nature. 2008 Oct 30;455(7217):1210-5
pubmed: 18724360
Am J Physiol Cell Physiol. 2001 Jun;280(6):C1485-97
pubmed: 11350744
J Biol Chem. 2011 Jul 29;286(30):26277-86
pubmed: 21606493
Am J Respir Crit Care Med. 2015 Jul 15;192(2):182-90
pubmed: 25909230
J Cell Sci. 2012 Nov 1;125(Pt 21):5051-60
pubmed: 22946048
Am J Respir Cell Mol Biol. 2010 Jul;43(1):55-63
pubmed: 19675306
J Biol Chem. 2005 Oct 21;280(42):35751-9
pubmed: 16087672
Purinergic Signal. 2008 Jun;4(2):139-46
pubmed: 18368524
J Physiol. 2007 Apr 15;580(Pt. 2):577-92
pubmed: 17317749
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14120-5
pubmed: 11707576
Curr Opin Pharmacol. 2009 Jun;9(3):262-7
pubmed: 19285919
Am J Respir Cell Mol Biol. 2013 Nov;49(5):814-20
pubmed: 23763446
J Biol Chem. 2006 Aug 11;281(32):22992-3002
pubmed: 16754672
J Biol Chem. 2010 Mar 12;285(11):8138-47
pubmed: 20071341
Purinergic Signal. 2012 Sep;8(3):359-73
pubmed: 22528679
FASEB J. 2005 Jan;19(1):142-3
pubmed: 15504951
J Biol Chem. 1998 May 29;273(22):14053-8
pubmed: 9593757
J Am Soc Nephrol. 2005 Nov;16(11):3182-7
pubmed: 16192420
Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):208-13
pubmed: 18635403
J Physiol. 2007 Oct 1;584(Pt 1):245-59
pubmed: 17656429
Am J Physiol Lung Cell Mol Physiol. 2020 Feb 1;318(2):L356-L365
pubmed: 31800264
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5683-6
pubmed: 18375752
J Physiol. 2010 Jun 15;588(Pt 12):2255-67
pubmed: 20421285
Sci Rep. 2017 Jul 27;7(1):6687
pubmed: 28751666
J Biol Chem. 1997 Feb 21;272(8):4978-84
pubmed: 9030559
Sci Signal. 2013 Jun 11;6(279):ra46
pubmed: 23757023
J Biol Chem. 2009 Jul 31;284(31):20638-48
pubmed: 19439413
J Biol Chem. 2010 Jun 4;285(23):17406-16
pubmed: 20382737
Am J Physiol. 1997 Mar;272(3 Pt 1):C1058-66
pubmed: 9124508
Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L614-24
pubmed: 16963528
J Biol Chem. 2010 Oct 15;285(42):32227-32
pubmed: 20709758
Annu Rev Physiol. 2006;68:543-61
pubmed: 16460283
Mol Biol Cell. 2010 Aug 1;21(15):2639-48
pubmed: 20554763
Pflugers Arch. 2007 Oct;455(1):169-80
pubmed: 17605040
J Biol Chem. 2011 Jul 15;286(28):25363-76
pubmed: 21613220
N Engl J Med. 2017 Sep 7;377(10):911-922
pubmed: 28877023
Nature. 2013 Mar 14;495(7440):223-6
pubmed: 23467090
J Biol Chem. 2004 Aug 27;279(35):36855-64
pubmed: 15210701
J Biol Chem. 2020 Apr 17;295(16):5192-5203
pubmed: 31988241
Cell. 1998 Dec 23;95(7):1005-15
pubmed: 9875854
Annu Rev Med. 2007;58:157-70
pubmed: 17217330
Am J Respir Cell Mol Biol. 2009 Nov;41(5):525-34
pubmed: 19213873
Cell. 2008 Sep 19;134(6):1019-29
pubmed: 18805094
Am J Physiol Cell Physiol. 2013 May 15;304(10):C976-84
pubmed: 23467297
J Biol Chem. 2000 Oct 6;275(40):31061-8
pubmed: 10913128
Proc Am Thorac Soc. 2004;1(1):66-70
pubmed: 16113415
Pharmacol Ther. 2009 Mar;121(3):332-48
pubmed: 19059283
J Gen Physiol. 1999 Oct;114(4):525-33
pubmed: 10498671
Science. 2012 Aug 24;337(6097):937-41
pubmed: 22923574
Am J Respir Cell Mol Biol. 2011 Aug;45(2):253-60
pubmed: 20935191

Auteurs

Catharina van Heusden (C)

Marsico Lung Institute/Cystic Fibrosis Center, School of Medicine, University of North Carolina, Chapel Hill, NC 27599-7248, USA.

Barbara R Grubb (BR)

Marsico Lung Institute/Cystic Fibrosis Center, School of Medicine, University of North Carolina, Chapel Hill, NC 27599-7248, USA.

Brian Button (B)

Marsico Lung Institute/Cystic Fibrosis Center, School of Medicine, University of North Carolina, Chapel Hill, NC 27599-7248, USA.

Eduardo R Lazarowski (ER)

Marsico Lung Institute/Cystic Fibrosis Center, School of Medicine, University of North Carolina, Chapel Hill, NC 27599-7248, USA.

Classifications MeSH